chevron_leftBack
As of 10 June 2026, PT Kimia Farma Tbk has a market cap of $147.12M USD, ranking #22972 globally and #320 in Indonesia.
It ranks #2069 in the Healthcare sector, and #745 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$147.12MUSD
2.67T IDR
Enterprise Value
$520.88MUSD
9.46T IDR
Revenue (TTM)
$507.85MUSD
9.22T IDR
EBITDA (TTM)
$12.09MUSD
219.58B IDR
Net Income (TTM)
-$18.44MUSD
-334.96B IDR
EBITDA Margin
2.4%
Profit Margin
-3.6%
PS Ratio
0.3
PB Ratio
1.0
EV/EBITDA
26.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Djagad Dwialam
open_in_new
Employees
9,838
Founded
1817
Website
kimiafarma.co.id
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.4% | -7.2% | 3% | -6.3% | -22% | 8.6% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
KAEF
PT Kimia Farma Tbk Class B
ISIN: ID1000070303
Shares Out.:
Shares Outstanding:
5.567B1
Shares Float:
277.873M2
|
478.00 IDR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About PT Kimia Farma Tbk
PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as well as trades in and distributes drugs to pharmacies, hospital pharmacy installation, medical center, and drug store. In addition, it produces quinine salt and its derivatives, as well as essential oils. PT Kimia Farma Tbk was founded in 1817 and is headquartered in Jakarta, Indonesia.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
IDX: KLBF
|
$2.18B
1K%
39.63T IDR
|
10.9
|
|
IDX: SOHO
|
$1.35B
814%
24.43T IDR
|
40.7
|
|
IDX: PYFA
|
$200.46M
36%
3.64T IDR
|
-
|
|
IDX: MERK
|
$106.07M
-28%
1.93T IDR
|
7.9
|
|
IDX: DVLA
|
$98.98M
-33%
1.8T IDR
|
10.4
|
|
IDX: IKPM
|
$18.92M
-87%
343.67B IDR
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
518K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
372K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
245K%
|
97.4
|
|
SIX: RO
|
$321.17B
218K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.57B
195K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.35B
186K%
218.9B CHF
|
20.5
|
chevron_leftBack